GE Marquette wins awards, signs GPO contract

Article

GE Marquette Medical Systems has garnered two awards from research firm Frost & Sullivan for its use of market research: the Competitive Strategy Award and the Product Line Strategy Award.These awards are based on independent research and analysis of

GE Marquette Medical Systems has garnered two awards from research firm Frost & Sullivan for its use of market research: the Competitive Strategy Award and the Product Line Strategy Award.

These awards are based on independent research and analysis of companies in the healthcare industry. GE Marquette stood out as a sole-source provider of clinical information systems and devices for patient monitoring and cardiology, and the company has been recognized for forming Web-based alliances to keep it competitive, according to Mahpara Qureshi, Frost & Sullivan industry analyst.

GE Marquette’s alliances with companies that produce technology complementary to its own products include Draeger, Critikon, NEC Medical Systems, CardioDynamics, Novametrix, Micro Medical, Data Critical, and Aspect Medical Systems. Wisconsin-based GE Marquette’s products focus on diagnostic cardiology, patient monitoring, and clinical information systems.

Recently, GE Marquette signed a three-year contract with Consorta Catholic Resource Partners to provide patient monitoring systems and services to its 900 hospitals and clinics around the world.

Under this agreement, GE Marquette will be a preferred provider of patient monitoring solutions, including the Solar family of advanced vital sign monitoring systems, the Eagle model configured monitors, and the portable Dash monitor, which supports continuous patient monitoring during an ambulance or aircraft ride.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.